Table 1.
Antiretroviral agents (by mechanism of action) used in contemporary management of HIV.
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) | Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) | Protease Inhibitors (PIs) | Integrase Strand Transfer Inhibitors (INSTIs) | CCR5 Antagonist | CD4-Directed Post-Attachment Inhibitor | Attachment Inhibitor |
|---|---|---|---|---|---|---|
| Abacavir (ABC) | Doravirine (DOR) | Atazanavir (ATV) | Raltegravir (RAL) | Maraviroc (MVC) | Ibalizumab (IBA) | Fostemsavir (FTR) |
| Emtricitabine (FTC) | Efavirenz (EFV) | Darunavir (DRV) | Elvitegravir (EVG) | |||
| Lamivudine (3TC) | Etravirine (ETR) | Lopinavir (LPV) | Dolutegravir (DTG) | |||
| Tenofovir disoproxil fumarate (TDF) | Rilpivirine (RPV) | Bictegravir (BIC) | ||||
| Tenofovir alafenamide (TAF) | Cabotegravir (CAB) |